MENU
PLX
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Protalix BioTherapeutics (PLX) Ownership - Who owns Protalix BioTherapeutics?
Industry: @Servicestothe Health Industry
Profile
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
208
Web
https://www.protalix.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
75.01M
P/E Ratio
13.00
Total Cash
45.03M
Projected Growth
N/A
Total Debt
26.15M
Revenue
38.05M
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash/Share
0.61
Total Debt/Equity
N/A
Revenue/Share
0.48 USD as % of share price
Fundamentals
PLX
Capitalization
75M
P/E Ratio
13.00
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash
45M
Total Cash/Share
0.61
Total Debt
26.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.48%
Revenue
38.1M
ROE
N/A
Book Value
28.6M
P/B Ratio
2.62
Cash Flow
N/A
Earnings
-0.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
73K
Current Ratio
1.33
Current Revenue Per Employee
64778.85
Dividends Per Share - Security
N/A
EBITDA
-12.12M
Float
N/A
Float - Current
N/A
Gross Income Margin
29.82
Revenue To Assets
-16.33
Shares Held By Institutions
10.9M
Shares Outstanding - Current
73.5M
Total Liabilities
63M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-38.764
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of recombinant therapeutic proteins
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
208
Web
https://www.protalix.com